Idraparinux
Medication
Idraparinux sodium is an anticoagulant medication in development by Sanofi-Aventis.
It has a similar chemical structure and the same method of action as fondaparinux, but with an elimination half-life about five to six times longer, which means... Wikipedia
Elimination half-life: 80-130 hours